Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+0.51%
-3.52%
0.00%
-44.79%
HRTX
Heron Therapeutics I
$2.11
Chart
2.2
1.78
1.51
3.44
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.51%
-3.52%
0.00%
-44.79%
HRTX
Heron Therapeutics I
$2.11
Chart
2.2
1.78
1.51
3.44
HRTX Latest Headlines
Heron Therapeutics GAAP EPS of $0.01 beats by $0.02 revenue of $38.9M beats by $1.48M.
Tue May 6, 2025
Heron Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Corporate Updates. Generated Q1 2025 Net Revenue of Delivered record Q1 2025 Adjusted EBITDA of Reached settlement with Mylan Pharmaceuticals Inc. regarding the parties'. CINVANTI®. and APONVIE®. patent litigations including an agreed market entry date of Adjusted EBITDA guidance raised to a range of ) (".Heron". or the ".Company".) a commercial-stage biotechnology company today announc
Tue May 6, 2025
Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating Officer. ) (".Heron". or the ".Company".) a commercial-stage biotechnology company today announced the appointment of Mark Hensley as Chief Operating Officer. Mr. Hensley has more than fifteen years of experience in a variety of sales and operations positions within the pharmaceutical industry.".I am excited to welcome Mark to Heron as our new Chief Operating Officer". said Mr. Hensley brings extensive
Mon Apr 28, 2025
Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday May 6 2025. ) (".Heron". or the ".Company".) a commercial-stage biotechnology company today announced that the Company will host a conference call and live webcast on The conference call can be accessed by phone by utilizing the following which will provide participants with dial-in details. To avoid delays we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled sta
Tue Apr 22, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
HRTX Stock trends
HRTX Stock performance
HRTX Stock analysis
HRTX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Login to display Heron Therapeutics I (HRTX) recommendation from the last 90 days from financial news and social media.
Hover over the category for more information
